Inventor · disambiguated record
Robert F. Kaiko
Also filed as: KAIKO ROBERT · KAIKO ROBERT F · KAIKO ROBERT FRANCIS
30 granted patents·33 pending applications·6,302 citations·filing 1992–2016
99Inventor score
Files withPURDUE PHARMA LP27EURO CELTIQUE SA13PURDUE PHARMA COMPANY5KAIKO ROBERT F2OSHLACK BENJAMIN2
Top patents by PatentIndex Score
63 records- 0199US7419686B2Opioid agonist/antagonist combinationsPURDUE PHARMA LP·Filed 2006·Granted Sep 2, 2008·105 cites·27 claims
- 0299US7172767B2Opioid agonist / antagonist combinationsPURDUE PHARMA LP·Filed 2003·Granted Feb 6, 2007·189 cites·21 claims
- 0399US6696066B2Opioid agonist/antagonist combinationsEURO CELTIQUE SA·Filed 2002·Granted Feb 24, 2004·335 cites·63 claims
- 0499US6475494B2Opioid agonist/antagonist combinationsEURO CELTIQUE SA·Filed 2001·Granted Nov 5, 2002·258 cites·23 claims
- 0599US6375957B1Opioid agonist/opioid antagonist/acetaminophen combinationsEURO CELTIQUE SA·Filed 2000·Granted Apr 23, 2002·595 cites·55 claims
- 0699US6277384B1Opioid agonist/antagonist combinationsEURO CELTIQUE SA·Filed 1998·Granted Aug 21, 2001·348 cites·50 claims
- 0799US5672360AMethod of treating pain by administering 24 hour oral opioid formulationsPURDUE PHARMA LP·Filed 1994·Granted Sep 30, 1997·492 cites·14 claims
- 0899US5478577AMethod of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelEURO CELTIQUE SA·Filed 1993·Granted Dec 26, 1995·470 cites·10 claims
- 0998US8822487B2Opioid agonist/opioid antagonist/acetaminophen combinationsPURDUE PHARMA LP·Filed 2012·Granted Sep 2, 2014·33 cites·17 claims
- 1098US7749542B2Opioid agonist/antagonist combinationsPURDUE PHARMA LP·Filed 2008·Granted Jul 6, 2010·63 cites·25 claims
- 1198US6627635B2Method of preventing abuse of opioid dosage formsEURO CELTIQUE SA·Filed 2001·Granted Sep 30, 2003·297 cites·23 claims
- 1298US6228863B1Method of preventing abuse of opioid dosage formsEURO CELTIQUE SA·Filed 1998·Granted May 8, 2001·590 cites·34 claims
- 1398US6143322AMethod of treating humans with opioid formulations having extended controlled releasePURDUE PHARMA LP·Filed 1997·Granted Nov 7, 2000·326 cites·13 claims
- 1498US5968547AMethod of providing sustained analgesia with buprenorphineEURO CELTIQUE SA·Filed 1997·Granted Oct 19, 1999·205 cites·47 claims
- 1598US5656295AControlled release oxycodone compositionsEURO CELTIQUE SA·Filed 1996·Granted Aug 12, 1997·491 cites·10 claims
- 1698US5549912AControlled release oxycodone compositionsEURO CELTIQUE SA·Filed 1992·Granted Aug 27, 1996·522 cites·9 claims
- 1797US8105631B2Opioid agonist/antagonist combinationsKAIKO ROBERT F·Filed 2010·Granted Jan 31, 2012·65 cites·25 claims
- 1897US6344212B2Method of providing sustained analgesia with buprenorphineEURO CELTIQUE SA·Filed 2001·Granted Feb 5, 2002·81 cites·24 claims
- 1997US5508042AControlled release oxycodone compositionsEURO CELTIGUE S A·Filed 1995·Granted Apr 16, 1996·676 cites·2 claims
- 2096US8936808B1Opioid agonist/opioid antagonist/acetaminophen combinationsPURDUE PHARMA LP·Filed 2014·Granted Jan 20, 2015·13 cites·30 claims
- 2196US8673355B2Opioid agonist/antagonist combinationsKAIKO ROBERT F·Filed 2011·Granted Mar 18, 2014·33 cites·36 claims
- 2295USRE41571EMethod of providing sustained analgesia with buprenorphinePURDUE PHARMA LP·Filed 2007·Granted Aug 24, 2010·20 cites·60 claims
- 2395USRE41489EMethod of providing sustained analgesia with buprenorphinePURDUE PHARMA LP·Filed 2007·Granted Aug 10, 2010·20 cites·28 claims
- 2494US8932630B1Opioid agonist/antagonist combinationsPURDUE PHARMA LP·Filed 2014·Granted Jan 13, 2015·13 cites·30 claims
- 2592US9205082B2Opioid agonist/antagonist combinationsPURDUE PHARMA LP·Filed 2014·Granted Dec 8, 2015·9 cites·29 claims
- 2692USRE41408EMethod of providing sustained analgesia with buprenorpinePURDUE PHARMA LP·Filed 2007·Granted Jun 29, 2010·11 cites·23 claims
- 2791US9474750B2Opioid agonist/opioid antagonist/acetaminophen combinationsPURDUE PHARMA LP·Filed 2014·Granted Oct 25, 2016·4 cites·26 claims
- 2884US6231886B1Methods of providing sustained treatment with opioidsFiled 1999·Granted May 15, 2001·30 cites·11 claims
- 2981US9642850B2Method of providing sustained analgesia with buprenorphinePURDUE PHARMA LP·Filed 2016·Granted May 9, 2017·1 cites·4 claims
- 3078US7740881B1Method of treating humans with opioid formulations having extended controlled releasePURDUE PHARMA LP·Filed 2000·Granted Jun 22, 2010·7 cites·23 claims
- 3175US2010034876A1Controlled release oxycodone compositionsPURDUE PHARMA LP·Filed 2009·Application pending·0 cites
- 3275US2010092570A1Controlled release oxycodone compositionsPURDUE PHARMA LP·Filed 2009·Application pending·0 cites
- 3374US2008031963A1Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelPURDUE PHARMA LP·Filed 2007·Application pending·0 cites
- 3474US2007237833A1Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelPURDUE PHARMA LP·Filed 2007·Application pending·0 cites
- 3572US2006269604A1Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelPURDUE PHARMA LP·Filed 2006·Application pending·0 cites
- 3671US2010209351A1Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelSACKLER RICHARD S·Filed 2009·Application pending·0 cites
- 3771US2010209514A1Method of treating pain by administering 24 hour oral oploid formulations exhibiting rapid rate of initial rise of plasma drug levelSACKLER RICHARD S·Filed 2009·Application pending·0 cites
- 3870US2006165792A1Controlled release oxycodone compositionsPURDUE PHARMA COMPANY·Filed 2006·Application pending·0 cites
- 3970US2006099255A1Controlled release oxycodone compositionsOSHLACK BENJAMIN·Filed 2005·Application pending·0 cites
- 4070US2006165791A1Controlled release oxycodone compositionsPURDUE PHARMA COMPANY·Filed 2006·Application pending·0 cites
- 4169US2015157625A1Method of providing sustained analgesia with buprenorphinePURDUE PHARMA LP·Filed 2014·Application pending·0 cites
- 4269US2008075781A1Controlled release oxycodone compositionsPURDUE PHARMA COMPANY·Filed 2007·Application pending·0 cites
- 4368US2017020865A1Opioid agonist/opioid antagonist/acetaminophen combinationsPURDUE PHARMA LP·Filed 2016·Application pending·0 cites
- 4468US2007275062A1Controlled release oxycodone compositionsOSHLACK BENJAMIN·Filed 2007·Application pending·0 cites
- 4567US2014073663A1Method of providing sustained analgesia with buprenorphinePURDUE PHARMA LP·Filed 2013·Application pending·0 cites
- 4666US2007237832A1Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug levelPURDUE PHARMA LP·Filed 2007·Application pending·0 cites
- 4766US2004105887A1Controlled release oxycodone compositionsFiled 2003·Application pending·0 cites
- 4865US2013197020A1Method of Providing Sustained Analgesia With BuprenorphinePURDUE PHARMA LP·Filed 2012·Application pending·0 cites
- 4964US2006216340A1Method of providing sustained analgesia with buprenorphineEURO CELTIQUE SA·Filed 2006·Application pending·0 cites
- 5063US2016051539A1Opioid agonist/antagonist combinationsPURDUE PHARMA LP·Filed 2015·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert F. Kaiko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →